Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Nm23/nucleoside diphosphate kinase-A as a potent prognostic marker in invasive pancreatic ductal carcinoma identified by proteomic analysis of laser micro-dissected formalin-fixed paraffin-embedded tissue.

Takadate T, Onogawa T, Fujii K, Motoi F, Mikami S, Fukuda T, Kihara M, Suzuki T, Takemura T, Minowa T, Hanagata N, Kinoshita K, Morikawa T, Shirasaki K, Rikiyama T, Katayose Y, Egawa S, Nishimura T, Unno M.

Clin Proteomics. 2012 Jun 27;9(1):8. doi: 10.1186/1559-0275-9-8.

2.

Novel prognostic protein markers of resectable pancreatic cancer identified by coupled shotgun and targeted proteomics using formalin-fixed paraffin-embedded tissues.

Takadate T, Onogawa T, Fukuda T, Motoi F, Suzuki T, Fujii K, Kihara M, Mikami S, Bando Y, Maeda S, Ishida K, Minowa T, Hanagata N, Ohtsuka H, Katayose Y, Egawa S, Nishimura T, Unno M.

Int J Cancer. 2013 Mar 15;132(6):1368-82. doi: 10.1002/ijc.27797. Epub 2012 Sep 14.

3.

c-erbB-2, p53, and nm23 proteins as prognostic factors in patients with epithelial ovarian carcinoma.

Tomić S, Ilić Forko J, Babić D, Sundov D, Kuret S, Andelinović S.

Croat Med J. 2003 Aug;44(4):429-34.

4.

Nm23 protein expression in ductal in situ and invasive human breast carcinoma.

Royds JA, Stephenson TJ, Rees RC, Shorthouse AJ, Silcocks PB.

J Natl Cancer Inst. 1993 May 5;85(9):727-31.

PMID:
8386774
5.

Prognostic significance of Nm23/NDPK expression in breast carcinoma, assessed on 10-year follow-up by automated and quantitative immunocytochemical assays.

Charpin C, Garcia S, Bonnier P, Martini F, Andrac L, Horschowski N, Lavaut MN, Allasia C.

J Pathol. 1998 Apr;184(4):401-7.

PMID:
9664906
6.

Altered expression of nm23-H1 and c-erbB-2 proteins have prognostic significance in adenocarcinoma but not in squamous cell carcinoma of the uterine cervix.

Mandai M, Konishi I, Koshiyama M, Komatsu T, Yamamoto S, Nanbu K, Mori T, Fukumoto M.

Cancer. 1995 May 15;75(10):2523-9.

PMID:
7736397
7.
8.

Immunohistochemical evaluation of nm23-H1 gene product in transitional cell carcinoma of the bladder.

Nakopoulou LL, Constandinides CA, Tzonou A, Lazaris AC, Zervas A, Dimopoulos CA.

Histopathology. 1996 May;28(5):429-35.

PMID:
8735718
9.

Expression of nm23/nucleoside diphosphate kinase-A protein in endometrial carcinoma.

Srivatsa PJ, Cliby WA, Keeney GL, Suman VJ, Harmsen WS, Ziesmer SC, Roche PC, Podratz KC.

Gynecol Oncol. 1997 Aug;66(2):238-45.

PMID:
9264569
10.

NM23 as a prognostic biomarker in ovarian serous carcinoma.

Youn BS, Kim DS, Kim JW, Kim YT, Kang S, Cho NH.

Mod Pathol. 2008 Jul;21(7):885-92. doi: 10.1038/modpathol.2008.64. Epub 2008 Apr 11.

11.

Expression of nm23 in gastric carcinoma: association with tumor progression and poor prognosis.

Müller W, Schneiders A, Hommel G, Gabbert HE.

Cancer. 1998 Dec 15;83(12):2481-7.

PMID:
9874452
12.

Prognostic significance of nm23 gene product expression in patients with colorectal carcinoma treated with radical intent.

Soliani P, Ziegler S, Romani A, Corcione L, Campanini N, Dell'Abate P, Del Rio P, Sianesi M.

Oncol Rep. 2004 Jun;11(6):1193-200.

PMID:
15138555
13.

Claudin-4 expression predicts survival in pancreatic ductal adenocarcinoma.

Tsutsumi K, Sato N, Tanabe R, Mizumoto K, Morimatsu K, Kayashima T, Fujita H, Ohuchida K, Ohtsuka T, Takahata S, Nakamura M, Tanaka M.

Ann Surg Oncol. 2012 Jul;19 Suppl 3:S491-9. doi: 10.1245/s10434-011-1970-2. Epub 2011 Aug 12.

PMID:
21837532
14.

Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma.

Srivatsa PJ, Cliby WA, Keeney GL, Dodson MK, Suman VJ, Roche PC, Podratz KC.

Gynecol Oncol. 1996 Mar;60(3):363-72.

PMID:
8774640
15.
16.

[Immunohistochemical analysis of nm23 gene product/nucleoside-diphosphate kinase expression in human lung carcinoma].

Jiang Y, He A, Xia S.

Zhonghua Jie He He Hu Xi Za Zhi. 1995 Aug;18(4):209-11, 254. Chinese.

PMID:
8697510
17.

Prognostic significance of p53, nm23, PCNA and c-erbB-2 in gastric cancer.

Lee KE, Lee HJ, Kim YH, Yu HJ, Yang HK, Kim WH, Lee KU, Choe KJ, Kim JP.

Jpn J Clin Oncol. 2003 Apr;33(4):173-9.

PMID:
12810831
18.

Immunohistologic detection of nm23-H1 protein in squamous cell carcinoma of the vulva.

Hantschmann P, Beysiegel S, Assemi C, Kurzl R.

J Reprod Med. 2004 Oct;49(10):787-95.

PMID:
15568401
19.

Expression of nm23-H1 gene product in esophageal squamous cell carcinoma and its association with vessel invasion and survival.

Tomita M, Ayabe T, Matsuzaki Y, Edagawa M, Maeda M, Shimizu T, Hara M, Onitsuka T.

BMC Cancer. 2001;1:3. Epub 2001 Apr 19.

20.

Clinical significance of p53, nm23, and bcl-2 in T3-4N1M0 oesophageal carcinoma: an immunohistochemical approach.

Patel DD, Bhatavdekar JM, Chikhlikar PR, Patel YV, Shah NG, Ghosh N, Suthar TP, Balar DB.

J Surg Oncol. 1997 Jun;65(2):111-6.

PMID:
9209522

Supplemental Content

Support Center